USP forum goes gratis
This article was originally published in The Tan Sheet
Executive SummaryThe Pharmacopeial Forum becomes a free online resource starting in January, the U.S. Pharmacopeia says Sept. 8, allowing "greater participation in the standards-setting process for drugs, excipients and dietary supplements." PF is the nonprofit group's journal for public comment, giving manufacturers, regulators and other stakeholders a chance to provide feedback on proposed standards before they become official in USP's National Formulary. The May-June issue of PF sought comments on standards for bacopa monnieri, garcinia gummi-gutta and other Indian botanicals used in supplements and traditional medicines (1"The Tan Sheet" May 10, 2010, In Brief)
You may also be interested in...
AstraZeneca will reacquire Allergan's investigational IL-23 inhibitor brazikumab, and Nestle is to buy its GI drug Zenpep, which had nine-month revenue of $208m.
The US agency is engaged with an ethylene oxide (EtO) sterilizer in Illinois that has temporarily closed to determine if there are any potential risks to the medical device supply chain. While the plant shut down about a month ago, regulators have only recently been made aware of the decision, which resulted from a law passed last year by the state legislature.